Abstract
Background: Diabetes Mellitus (DM) is a major emerging health issue and the risk factors are varied in women making them susceptible to it. Metformin is most preferred and widely used drug worldwide due to various reasons. Vitamin B12 deficiency in DM caused by Metformin is least known side effect. Objective: This study was taken up to assess the correlation between deficiency and duration and dose of metformin treatment. Methods: This being a hospital based observational study, 650 Diabetic women were evaluated by detailed questionnaire, general physical examination, fasting blood glucose (FBS), post prandial blood glucose (PPBS), serum Vitamin B12 levels, CBC and NCS. Results: The mean age of the cases was 51.98±5.17years. 164/408 cases (on metformin therapy for >3 months) had low vitamin B12 as against 22/242 controls (never on metformin therapy). Mean Serum vitamin B12 was low in cases with less duration of DM when compared to cases with longer duration. Vitamin B12 deficiency was correlated with anemia and neuropathy. Conclusions: Metformin treatment in cases is associated with higher prevalence of Vitamin B12 deficiency which increases with duration of DM and dose of metformin. Deficiency correlated with development of macrocytic anemia and worsening of neuropathy. In some, symptoms of deficiency are difficult to diagnose and can be irreversible if left untreated (like neuropathy). Routine screening of Vitamin B12 levels, CBC, NCS should be done in all diabetic women at the beginning of metformin therapy, and yearly thereafter. Treatment and prevention of deficiency is easy, cheap, safe, and effective.
Highlights
Type 2 Diabetes Mellitus (NIDDM) being the most common endocrine disease, is the major cause of morbidity and mortality affecting millions of people worldwide
This being a hospital based observational study, 650 Diabetic women were evaluated by detailed questionnaire, general physical examination, fasting blood glucose (FBS), post prandial blood glucose (PPBS), serum Vitamin B12 levels, CBC and NCS
Metformin treatment in diabetic women is associated with higher prevalence of Vitamin B12 deficiency
Summary
Type 2 Diabetes Mellitus (NIDDM) being the most common endocrine disease, is the major cause of morbidity and mortality affecting millions of people worldwide. Research has shown that many risk factors like obesity, lack of physical activity, family commitments and pressures are more common among women than men in all population subgroups. Circumstances such as retirement from employment, separation, divorce, and widowhood may make middle-aged women vulnerable to low family incomes and inadequate health care coverage so that they may forego needed services, including preventive care for diabetes [1]. Objective: This study was taken up to assess the correlation between deficiency and duration and dose of metformin treatment. Conclusions: Metformin treatment in cases is associated with higher prevalence of Vitamin B12 deficiency which increases with duration of DM and dose of metformin. Treatment and prevention of deficiency is easy, cheap, safe, and effective
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
